“Tutalthromycin second gen”的搜索结果

8 个项目

每页

设置降序顺序
  1. GDC-0927 Racemate

    Catalog No. A21507
    Quick View
    estrogen receptor degrader
    GDC-0927 Racemate (SRN-927 Racemate) is a degrader of estrogen receptor, potently inhibits ER-α activity, with an IC50 of 0.2 nM, and is used in the research of ER-related diseases. 了解更多
  2. Elacestrant

    Catalog No. A12244
    Quick View
    Estrogen receptor degrader
    Elacestrant (RAD1901) is an orally available selective estrogen receptor degrader (SERD) with IC50s of 48 and 870 nM for ERα and ERβ, respectively. 了解更多
  3. PROTAC ER Degrader-3

    Catalog No. A18519
    Quick View
    PROTAC ER Degrader-3 is an intermediate for synthesis of PAC. PAC, consists the ADCs linker and PROTACs, conjugated to an antibody. PAC extracts from patent WO2017201449A1, compound LP2. PAC conjugated to an antibody is a more marked estrogen receptor-alpha (ERα) degrader compared to PROTAC (without Ab). 了解更多
  4. PROTAC ERRα Degrader-2

    Catalog No. A18904
    Quick View
    ERRa degrader
    PROTAC ERRalpha Degrader-2 comprises a MDM2 ligand binding group, a linker and an estrogen-related receptor alpha (ERRa) binding group. PROTAC ERRalpha Degrader-2 is an estrogen-related receptor alpha (ERRa) degrader. 了解更多
  5. PROTAC ERRα Degrader-1

    Catalog No. A18910
    Quick View
    ERRα Degrader
    PROTAC ERRα Degrader-1 comprises a MDM2 ligand binding group, a linker and an estrogen-related receptor alpha (ERRa) binding group. PROTAC ERRα Degrader-1 is an estrogen-related receptor alpha (ERRa) degrader. 了解更多
  6. ERD-308

    Catalog No. A18446
    Quick View
    ER PROTAC degrader
    ERD-308 is a highly potent PROTAC degrader of estrogen receptor (ER) for ER positive breast cancer treatment. 了解更多
    • 最新产品

    MD-224

    Catalog No. A18712
    Quick View
    MDM2 degrader
    MD-224 is a first-in-class and highly potent small-molecule human murine double minute 2 (MDM2) degrader based on the proteolysistargeting chimera (PROTAC) concept. MD-224 has the potential to be a new class of anticancer agent. 了解更多
  7. GDC-0810 (Brilanestrant)

    Catalog No. A15958
    Quick View
    Estrogen receptor degrader
    GDC-0810 (Brilanestrant)是一种口服可生物利用的选择性雌激素受体降解剂(SERD),在耐他莫昔芬的乳腺癌异种移植物中表现出强大的活性。 了解更多

8 个项目

每页

设置降序顺序
Rewards